Abstract
The cytidine deaminase APOBEC3G has been identified as an antiviral host factor that combats HIV-1. The protein was found to be present in HIV-1 target cells such as macrophages and dendritic cells. The antiviral state of these cells has been partially attributed to a G→A hypermutation of the HIV genome caused by APOBEC3G during reverse transcription. However, the viral infectivity factor (Vif) counteracts this antiviral mechanism by inducing the inactivation of APOBEC3G. In this study, we tested the effect of APOBEC3G expression on the HIV-1 infection of cells derived from purified CD34+ cells that have been transduced with lentiviral vectors containing APOBEC3G and/or shRNAs directed against APOBEC3G and then have been differentiated before infection with HIV-1. In cell lines, the infection was strongly inhibited after upregulation of APOBEC3G. The infection could then be rescued after transducing these cells with shRNAs targeting APOBEC3G. In cells derived from purified CD34+ cells a strong inhibition of the HIV-1 infection was observed in both a Vif defective HIV-1 virus and the corresponding wild-type HIV-1 virus with Vif. Our data implies that when APOBEC3G is expressed high enough, it can escape the inhibition from Vif, thereby exerting its antiviral activity.
Keywords: APOBEC3G, CD34+ cells, macrophages, lentiviral vectors, HIV-1, Vif, HIV-1 Infection, APOBEC3G Expression, cytidine deaminase, dendritic cell, GA hypermutation, HIV genome, Vif defective HIV-1 virus, wild-type HIV-1 virus, immune system, dendritic cells, T cells, hypermutations, cellular endonuclease, monocytes, nucleocapsid protein, HEK-293T, HeLa, TZM-bl cells, Dulbecco's modified Eagle's medium, DMEM, fetal bovine serum, glutamine, penicillin, streptomycin, stem cell transplantation, intraglobine, Pulmozyme, PBS, mercaptoethanol, sodium pyruvate, Flow Cytometry, immunofluorescent antibodies, FITC antibody, reverse transcription, Plasmid, Calcium Phosphate, Western Blot, anti-GAPDH antibody, p24 ELISA
Current HIV Research
Title: Regulation of HIV-1 Infection in Cells Derived from Purified CD34+ Cells Through Manipulation of APOBEC3G Expression.
Volume: 8 Issue: 7
Author(s): Anna Heinzelmann, Stefan Stein, Ulrike Kohl, Ursula Dietrich and Hagen von Briesen
Affiliation:
Keywords: APOBEC3G, CD34+ cells, macrophages, lentiviral vectors, HIV-1, Vif, HIV-1 Infection, APOBEC3G Expression, cytidine deaminase, dendritic cell, GA hypermutation, HIV genome, Vif defective HIV-1 virus, wild-type HIV-1 virus, immune system, dendritic cells, T cells, hypermutations, cellular endonuclease, monocytes, nucleocapsid protein, HEK-293T, HeLa, TZM-bl cells, Dulbecco's modified Eagle's medium, DMEM, fetal bovine serum, glutamine, penicillin, streptomycin, stem cell transplantation, intraglobine, Pulmozyme, PBS, mercaptoethanol, sodium pyruvate, Flow Cytometry, immunofluorescent antibodies, FITC antibody, reverse transcription, Plasmid, Calcium Phosphate, Western Blot, anti-GAPDH antibody, p24 ELISA
Abstract: The cytidine deaminase APOBEC3G has been identified as an antiviral host factor that combats HIV-1. The protein was found to be present in HIV-1 target cells such as macrophages and dendritic cells. The antiviral state of these cells has been partially attributed to a G→A hypermutation of the HIV genome caused by APOBEC3G during reverse transcription. However, the viral infectivity factor (Vif) counteracts this antiviral mechanism by inducing the inactivation of APOBEC3G. In this study, we tested the effect of APOBEC3G expression on the HIV-1 infection of cells derived from purified CD34+ cells that have been transduced with lentiviral vectors containing APOBEC3G and/or shRNAs directed against APOBEC3G and then have been differentiated before infection with HIV-1. In cell lines, the infection was strongly inhibited after upregulation of APOBEC3G. The infection could then be rescued after transducing these cells with shRNAs targeting APOBEC3G. In cells derived from purified CD34+ cells a strong inhibition of the HIV-1 infection was observed in both a Vif defective HIV-1 virus and the corresponding wild-type HIV-1 virus with Vif. Our data implies that when APOBEC3G is expressed high enough, it can escape the inhibition from Vif, thereby exerting its antiviral activity.
Export Options
About this article
Cite this article as:
Heinzelmann Anna, Stein Stefan, Kohl Ulrike, Dietrich Ursula and von Briesen Hagen, Regulation of HIV-1 Infection in Cells Derived from Purified CD34+ Cells Through Manipulation of APOBEC3G Expression., Current HIV Research 2010; 8 (7) . https://dx.doi.org/10.2174/157016210793499231
DOI https://dx.doi.org/10.2174/157016210793499231 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Arginyl Aminopeptidase-Like 1 (RNPEPL1) Is an Alternatively Processed Aminopeptidase with Specificity for Methionine, Glutamine, and Citrulline Residues
Protein & Peptide Letters Exercise Addiction- Diagnosis, Bio-Psychological Mechanisms and Treatment Issues
Current Pharmaceutical Design The Comprehensive Appraisal of COVID-19: Its’ Clinical Panorama from Virology till Management and Beyond
Coronaviruses Rational and Random Strategies for the Mimicry of Discontinuous Protein Binding Sites
Protein & Peptide Letters Contemporary Animal Models For Human Gene Therapy Applications
Current Gene Therapy The Nervous System as a Critical Regulator of Immune Responses Underlying Allergy
Current Pharmaceutical Design Anti-Inflammatory Drugs and Herbs with Special Emphasis on Herbal Medicines for Countering Inflammatory Diseases and Disorders - A Review
Recent Patents on Inflammation & Allergy Drug Discovery Prevention and Management of Hypertension Without Drugs
Current Hypertension Reviews Focus on Ulcerative Colitis: Stable Gastric Pentadecapeptide BPC 157
Current Medicinal Chemistry Targeting the MCP-1/CCR2 System in Diabetic Kidney Disease
Current Vascular Pharmacology Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads
Current Signal Transduction Therapy The Boundary between Hypochondriasis, Personality Dysfunction, and Trauma
Current Psychiatry Reviews The Role of Cytokines in Interactions of Mesenchymal Stem Cells and Breast Cancer Cells
Current Stem Cell Research & Therapy Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line
Anti-Cancer Agents in Medicinal Chemistry The Clinical Spectrum, Diagnosis, Pathogenesis and Treatment of Hashimotos Encephalopathy (Recurrent Acute Disseminated Encephalomyelitis)
Current Medicinal Chemistry Dendritic Cells: A New Player in Osteoimmunology
Current Molecular Medicine Effect of Intestinal Flora Clearance on Liver Proteomics in Mice
Current Proteomics Thrombotic Thrombocytopenic Purpura, from the Perspectives of a Pediatrician
Current Pediatric Reviews Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Curcumin - Properties, Applications and Modification of Structure
Mini-Reviews in Organic Chemistry